Trinity Biotech Glucose-6-Phosphate Dehydrogenase reagents are for the quantitative, ultraviolet, kinetic determination of G-6-PDH in blood at 340 nm.
50 manual tests
Hemolytic Anemia
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Sample Purifier Tubes are intended to be used to prepare samples to be tested with the Oxalate Reagent Kit or the quantitative, enzymatic determination of oxalate in urine at 590 nm.
20 tubes
Kidney Disease
FDA Cleared
Canada Cleared
CE Marked
IFU Documents
SDS Documents
Sample Purifier Tubes are intended to be used to prepare samples to be tested with the Oxalate Reagent Kit or the quantitative, enzymatic determination of oxalate in urine at 590 nm.
100 tubes
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Sample diluent is intended for use with the Trinity Biotech Oxalate Kits (591-C and 591-D) which are for the quantitative, enzymatic determination of oxalate in urine at 590 nm.
1000 ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Sample diluent is intended for use with the Trinity Biotech Oxalate Kits (591-C and 591-D) which are for the quantitative, enzymatic determination of oxalate in urine at 590 nm
100 ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Lyophilized human urine preparation containing a normal level of oxalate. It is designed for use as a control in the determination of oxalate according to Trinity Biotech Procedure No. 591.
6 x 5ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Lyophilized human urine preparation containing an elevated level of oxalate. It is designed for use as a control in the determination of oxalate according to Trinity Biotech Procedure No. 591.
6 x 5ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Oxalate Standards Set is intended for use with he Trinity Biotech Oxalate Kits (591-C and 591-D) which are for the quantitative, enzymatic determination of oxalate in urine at 590 nm “.
2×25 ml each of 0.25, 0.50 and 1.0 mmol/L
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Oxalate Standard is intended for use with the Trinity Biotech Oxalate Kits (591-C and 591-D) which are for the quantitative, enzymatic determination of oxalate in urine at 590 nm
25 ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Oxalate Reagent B is intended to be used with the Oxalate Reagent Kit or the quantitative, enzymatic determination of oxalate in urine at 590 nm.
2ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Oxalate Reagent A is intended to be used with the Oxalate Reagent Kit or the quantitative, enzymatic determination of oxalate in urine at 590 nm.
10ml
Kidney Disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
SDS Documents
Trinity Biotech Oxalate reagents are for the quantitative, enzymatic determination of oxalate in
urine at 590 nm.
Quantitative, Enzymatic
20 manual tests
Kidney Disease
FDA: Cleared
Canada: Cleared
CE Marked
IFU Documents
SDS Documents
Oxalate reagents are for the quantitative, enzymatic determination of oxalate in urine.
100 manual tests
Kidney Disease
FDA: Cleared
Canada: Cleared
CE Marked
IFU Documents
SDS Documents
For use with discrete analyser applications with the Trinity Biotech G-6-PDH quantitative kit (P/N: 345-B).
4 x 25 ml
Hemolytic Anemia
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Component of the 400K-100-5×20 and 400K-100X kits. Also separately available where required.
100 ml
Hemolytic Anemia
FDA
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Separately available component. May be used with G6PDH kits 400K-100-5×20 AND 400K-100X
1000 ml
Hemolytic Anemia
FDA
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
The G-6-PDH Control, Intermediate serves to verify procedure reliability when assayed with test samples. For in vitro diagnostic use.
6 x 0.5 ml
Hemolytic Anemia
FDA: Cleared
Canada: Cleared
CE: Marked
IFU Documents
SDS Documents
The G-6-PDH Control, Deficient serves to verify procedure reliability when assayed with test samples. For in vitro diagnostic use.
6 x 0.5 ml
Hemolytic Anemia
FDA: Cleared
Canada: Cleared
CE: Marked
The G-6-PDH Control, Normal serves to verify procedure reliability when assayed with test samples. For in vitro diagnostic use.
6 x 0.5 ml
Hemolytic Anemia
FDA: Cleared
Canada: Cleared
CE: Marked
IFU Document
SDS Documents
The G-6-PDH Deficiency Screen by Spot Test is a qualitative test is intended for the qualitative, visual fluorescence screening of G-6-PDH in whole blood.
The G-6-PDH Deficiency Screen by Spot Test is a qualitative test is intended for the qualitative, visual fluorescence screening of G-6-PDH in whole blood.
Trinity Biotech Glucose-6-Phosphate Dehydrogenase reagents are for the qualitative, visual
fluorescence screening of G-6-PDH in whole blood. Samples which have been determined
deficient or intermediate should be assayed by a quantitative G-6-PDH method such as Trinity
Biotech Procedure No. 345.
Qualitative, Visual Fluorescence Screening
50 manual tests
Hemolytic Anemia
FDA: Cleared
CE: Cleared
Canada: Cleared
Trinity Biotech Glucose-6-Phosphate Dehydrogenase (G-6-PDH) reagents are for the qualitative, visual, colorimetric determination of G-6-PDH deficiency in red cells.
100 manual tests
Hemolytic Anemia
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Trinity Biotech Glucose-6-Phosphate Dehydrogenase (G-6-PDH) reagents are for the qualitative, visual, colorimetric determination of G-6-PDH deficiency in red cells.
50 manual tests
Hemolytic Anemia
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Trinity Biotech Glucose-6-Phosphate Dehydrogenase (G-6-PDH) reagents are for the qualitative, visual, colorimetric determination of G-6-PDH deficiency in red cells.
100 manual tests
Hemolytic Anemia
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Stop Reagent intended to be used with the Bile Acids Reagent Kit.
50 ml
Liver disease
FDA: Cleared
CE: Cleared
Canada: Cleared
The Bile Acids Controls are designed for use in the assay of bile acids to verify procedure reliability.
1 set, 6x5ml
Liver disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Bile Acid: Calibrator Set contains calibrators for use in the quantitative, enzymatic determination of bile acids’ concentrations of serum.
5 ml
Liver disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
Bile Acid: Calibrator Set contains calibrators for use in the quantitative, enzymatic determination of bile acids’ concentrations of serum.
1 set 5x5ml
Liver disease
FDA: Cleared
Canada: Cleared
CE: Cleared
IFU Documents
SDS Versions
Bile Acids’ reagents are intended for the quantitative, enzymatic determination of bile acids concentrations of serum.
5 ml
Liver disease
FDA: Cleared
CE: Cleared
Canada: Cleared
Trinity Biotech Bile Acids reagents are intended for the quantitative, enzymatic determination of bile
acids concentration of serum at 530 nm.
50 ml
Liver disease
FDA: Cleared
Canada: Cleared
CE: Cleared
IFU Documents
SDS Versions
Trinity Biotech Bile Acids reagents are intended for the quantitative, enzymatic determination of bile
acids concentration of serum at 530 nm.
160 Manual tests
Liver disease
FDA: Cleared
Canada: Cleared
CE: Cleared
IFU Documents
SDS Versions
ACE Control-N is intended for use as a control in the determination of angiotensin converting enzyme (ACE).
6 x 1ml
Lung disease
FDA: Cleared
Canada: Cleared
CE: Marked
IFU Documents
SDS Documents
ACE Control-E is intended for use as a control in the determination of angiotensin converting enzyme (ACE)
6 x 1ml
Lung disease
FDA: Cleared
Canada: Cleared
CE: Marked
IFU Documents
SDS Documents
ACE Calibrator is intended to establish the point of reference in the kinetic determination of angiotensin converting enzyme (ACE) in human serum or plasma.
6 x 1ml
Lung disease
FDA: Cleared
CE: Cleared
Canada: Cleared
IFU Documents
SDS Documents
ACE Reagent is for use in the quantitative kinetic determination of angiotensin converting enzyme (ACE) activity in serum or plasma at 340 nm.
100 manual tests
Lung disease
FDA Cleared,
Canada Cleared,
CE Marked
IFU Documents
SDS Documents
SDS Versions
